Akamai Technologies, Inc. (AKAM - Free Report) : This provider of cloud services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Akamai’s shares gained 8.3% over the last one month more than S&P 500’s gain of 2.8%. The company possesses a Momentum Score of A.
Akamai Technologies, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. : This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Akamai Technologies, Inc. Price
AcelRx’s shares gained 34% over the last one month. The company possesses a Momentum Score of B.
AcelRx Pharmaceuticals, Inc. Price and Consensus
Allied Motion Technologies, Inc. : This operator and developer of pipelines and other midstream assets has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.9% over the last 60 days.
AcelRx Pharmaceuticals, Inc. Price
Allied Motion’s shares gained 4.2% over the last one month. The company possesses a Momentum Score of B.
Allied Motion Technologies, Inc. Price and Consensus
Allied Motion Technologies, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Akamai Technologies, Inc. (AKAM - Free Report) : This provider of cloud services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Akamai’s shares gained 8.3% over the last one month more than S&P 500’s gain of 2.8%. The company possesses a Momentum Score of A.
Akamai Technologies, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. : This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.
Akamai Technologies, Inc. Price
AcelRx’s shares gained 34% over the last one month. The company possesses a Momentum Score of B.
AcelRx Pharmaceuticals, Inc. Price and Consensus
Allied Motion Technologies, Inc. : This operator and developer of pipelines and other midstream assets has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.9% over the last 60 days.
AcelRx Pharmaceuticals, Inc. Price
Allied Motion’s shares gained 4.2% over the last one month. The company possesses a Momentum Score of B.
Allied Motion Technologies, Inc. Price and Consensus
Allied Motion Technologies, Inc. Price
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on AKAM - FREE